JP2018504391A5 - - Google Patents

Download PDF

Info

Publication number
JP2018504391A5
JP2018504391A5 JP2017533825A JP2017533825A JP2018504391A5 JP 2018504391 A5 JP2018504391 A5 JP 2018504391A5 JP 2017533825 A JP2017533825 A JP 2017533825A JP 2017533825 A JP2017533825 A JP 2017533825A JP 2018504391 A5 JP2018504391 A5 JP 2018504391A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
och
foregoing
solvate
following formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533825A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018504391A (ja
JP6665189B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/066725 external-priority patent/WO2016106133A1/en
Publication of JP2018504391A publication Critical patent/JP2018504391A/ja
Publication of JP2018504391A5 publication Critical patent/JP2018504391A5/ja
Application granted granted Critical
Publication of JP6665189B2 publication Critical patent/JP6665189B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533825A 2014-12-23 2015-12-18 κオピオイド受容体に対するN−メチル−N−(1−フェニル−2−(1−ピロリジニル)エチル)−2−アミノフェニルアセトアミド誘導体作動薬 Expired - Fee Related JP6665189B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3872/DEL/2014 2014-12-23
IN3872DE2014 2014-12-23
PCT/US2015/066725 WO2016106133A1 (en) 2014-12-23 2015-12-18 N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

Publications (3)

Publication Number Publication Date
JP2018504391A JP2018504391A (ja) 2018-02-15
JP2018504391A5 true JP2018504391A5 (enExample) 2019-01-24
JP6665189B2 JP6665189B2 (ja) 2020-03-13

Family

ID=55236907

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017533825A Expired - Fee Related JP6665189B2 (ja) 2014-12-23 2015-12-18 κオピオイド受容体に対するN−メチル−N−(1−フェニル−2−(1−ピロリジニル)エチル)−2−アミノフェニルアセトアミド誘導体作動薬

Country Status (4)

Country Link
US (2) US10322107B2 (enExample)
EP (1) EP3237388B1 (enExample)
JP (1) JP6665189B2 (enExample)
WO (1) WO2016106133A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815824B2 (en) * 2013-06-28 2017-11-14 Nektar Therapeutics Kappa opioid agonists and uses thereof
WO2016106133A1 (en) 2014-12-23 2016-06-30 Nektar Therapeutics N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor
US20230095235A1 (en) * 2020-03-11 2023-03-30 Purdue Pharma L.P. Compositions and methods for naloxone delivery

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4034785A1 (de) * 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232978A (en) 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
US6750216B2 (en) * 1996-03-08 2004-06-15 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
DK1694363T3 (en) 2003-12-16 2014-03-24 Nektar Therapeutics Monodisperse PEGylated Naloxole Compositions
US8173666B2 (en) 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
WO2014146111A2 (en) * 2013-03-15 2014-09-18 The Regents Of The University Of California Analgesic compounds and methods of use
US9815824B2 (en) * 2013-06-28 2017-11-14 Nektar Therapeutics Kappa opioid agonists and uses thereof
WO2016106133A1 (en) 2014-12-23 2016-06-30 Nektar Therapeutics N-methyl-n-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

Similar Documents

Publication Publication Date Title
JP2018021046A5 (enExample)
JP2016534063A5 (enExample)
JP2017531619A5 (enExample)
JP2017526716A5 (enExample)
JP2015024998A5 (enExample)
JP2013519675A5 (enExample)
JP2015537020A5 (enExample)
JP2013522326A5 (enExample)
JP2017514910A5 (enExample)
JP2019524883A5 (enExample)
JP2014500861A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2019516739A5 (enExample)
JP2016513130A5 (enExample)
JP2019505529A5 (enExample)
JP2015522589A5 (enExample)
JP2016510326A5 (enExample)
JP2016522254A5 (enExample)
JP2020097577A5 (enExample)
JP2018529742A5 (enExample)
JP2019535723A5 (enExample)
JP2015509075A5 (enExample)
JP2017505785A5 (enExample)
JP2016537338A5 (enExample)
JP2015516419A5 (enExample)